June 25, 2019

Are You Missing The Low Hanging Fruit?

As medical device company executives, it can be challenging to identify opportunities for performance improvement that can quickly and efficiently drive incremental profits to the bottom line.  New product development can often take years to successful launch into the marketplace, not to mention being highly capital intensive.  Expanding sales and marketing, also expensive, can also take time to gain traction.  These two strategic levers share a similarity, they both have a cost, tied to per […]
March 26, 2019
Innovation at REV.1 Engineering

Identifying and Managing Strategic Dollars in Device Development

Developing a medical device to commercialization is a complex, multi-faceted endeavor.  It’s also an expensive undertaking fraught with risk factors at each stage of development. While maintaining a meticulous attention to detail is paramount throughout the entire process, the fact of the matter is, some of the dollars you’ll be spending will inevitably be more strategic than others. Strategic dollars drive two areas of value creation.  First, strategic dollars intermediate critical risk factors from metastasizing […]
February 27, 2019

Strategic Engineering and Speed to Revenue

A REV•1 Engineering® White Paper Strategic Engineering is a comprehensive approach to medical device development that drives speed to revenue while simultaneously scrubbing away risk along the critical, developmental path.  This White Paper sets forth to examine the value of Strategic Engineering and how to go about adopting and implementing the approach. Strategic Engineering hinges on two key factors; highly coordinated resourcing combined with the rigorous execution of Design for Risk Management.  Perhaps a good […]
January 3, 2019

REV.1 Engineering Medical Device Client Closes on $77 Million Series D Round

Ablative Solutions (Kalamazoo, MI) announces major investment in support of their innovative device technology intended for the treatment of hypertension. MURRIETA, Calif. – Jan. 3, 2019 – PRLog — REV.1 Engineering is pleased to announce one of their long-standing, medical device development clients, Ablative Solutions (ASI), closed on $77 million in Series D equity financing today. “We’re very excited for this significant achievement for our friends at Ablative Solutions,” said Eric Johnson, CEO of REV.1 Engineering.  “It’s also a reflection of […]
X
Schedule a Conversation
Contact Us